News from camargo pharmaceutical services, llc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 09, 2018, 08:21 ET Camargo Congratulates US WorldMeds on Obtaining FDA Approval for the First Non-Opioid Medicine for the Management of Opioid Withdrawal Symptoms

Camargo Pharmaceutical Services, LLC, ("Camargo"), the global development and commercialization partner and industry leader utilizing the FDA...


Jun 01, 2018, 04:20 ET Camargo Celebrates Fifteen Years

June 1, 2018 marks the 15th anniversary for Camargo Pharmaceutical Services, LLC, ("Camargo"). Camargo has grown from a small strategic drug...


Apr 30, 2018, 08:41 ET Daniel S. Duffy - Ernennung zum neuen CEO von Camargo Pharmaceutical Services, LLC

Camargo Pharmaceutical Services, LLC, („Camargo"), der weltweit führende Anbieter von 505(b)(2)-Medikamentenentwicklung und global gleichwertigen...


Apr 30, 2018, 08:41 ET El Sr. Daniel S. Duffy es nombrado nuevo consejero delegado de Camargo Pharmaceutical Services, LLC

Camargo Pharmaceutical Services, LLC ("Camargo"), líder mundial en el desarrollo de fármacos de vía 505(b)(2) y equivalentes internacionales, ha...


Apr 30, 2018, 08:41 ET Daniel S. Duffy nommé nouveau PDG de Camargo Pharmaceutical Services, LLC

Camargo Pharmaceutical Services, LLC, (« Camargo »), le leader mondial en développement de médicaments 505(b)(2) et d'équivalents globaux, a annoncé...


Apr 30, 2018, 08:41 ET Daniel S. Duffy será o novo presidente-executivo da Camargo Pharmaceutical Services, LLC

A Camargo Pharmaceutical Services, LLC, ("Camargo"), líder mundial em desenvolvimento de medicamentos 505(b)(2) e equivalentes globais, anunciou hoje ...


Apr 30, 2018, 08:41 ET Daniel S. Duffy es designado nuevo CEO de Camargo Pharmaceutical Services, LLC

Camargo Pharmaceutical Services, LLC ("Camargo"), líder global en desarrollo de fármacos 505(b)(2) y equivalentes globales, anunció hoy la...


Apr 30, 2018, 08:41 ET Daniel S. Duffy - Appointed New CEO of Camargo Pharmaceutical Services, LLC

Camargo Pharmaceutical Services, LLC, ("Camargo") the global leader in 505(b)(2) drug development and global equivalents, today announced the...


Mar 06, 2018, 07:48 ET V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of Transformative Prodrug Technology Platform

V ClinBio Inc., an innovative biopharmaceutical company focused on transforming existing compounds into differentiated new therapeutics, today...